2020
DOI: 10.1016/j.jdiacomp.2020.107585
|View full text |Cite
|
Sign up to set email alerts
|

Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 102 publications
0
12
0
Order By: Relevance
“…However, the use of HbA1c as an ideal glycemic marker is currently disputed [141]. The HbA1c test is not always applicable.…”
Section: Hba1 and Mg-the Hyperglycemic Biomarkersmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the use of HbA1c as an ideal glycemic marker is currently disputed [141]. The HbA1c test is not always applicable.…”
Section: Hba1 and Mg-the Hyperglycemic Biomarkersmentioning
confidence: 99%
“…For a more accurate assessment of the risk of cardiovascular diseases at the early diabetes stages, the combined use of several parameters was suggested: fasting blood glucose, blood pressure, the amount of glutathione in RBCs, and total cholesterol [158]. Gycated albumin, fuctosamine, and 1,5-anhydroglucitol were also proposed as alternative glycemic markers [141]. These biomarkers are not yet used in the clinic practice due to the lack of standardization.…”
Section: Hba1 and Mg-the Hyperglycemic Biomarkersmentioning
confidence: 99%
“…Only the HbA1 test result was used to assess disease management. There has been a lot of discussion lately about the objectivity of this test in assessing disease control [54][55][56]. HbA1 shows only a three-to four-month mean glycaemic index, not glycaemic fluctuations.…”
Section: Significant Relationships Are Provided In Bold Or-odds Ratimentioning
confidence: 99%
“…This test is more expensive than a plasma glucose estimation. 11 Standardized monitoring systems and research laboratories are not widely used across the country, and evaluating HbA1c is more expensive than performing FPG assessments. Furthermore, there is no agreement on an appropriate HbA1c cutoff point for the diagnosis of diabetes in this high-risk population of countries, including India.…”
Section: Introductionmentioning
confidence: 99%